CNTA
Price
$15.73
Change
-$0.06 (-0.38%)
Updated
Sep 5 closing price
Capitalization
2.11B
71 days until earnings call
CRNX
Price
$35.61
Change
+$1.36 (+3.97%)
Updated
Sep 5 closing price
Capitalization
3.35B
60 days until earnings call
Interact to see
Advertisement

CNTA vs CRNX

Header iconCNTA vs CRNX Comparison
Open Charts CNTA vs CRNXBanner chart's image
Centessa Pharmaceuticals
Price$15.73
Change-$0.06 (-0.38%)
Volume$952.27K
Capitalization2.11B
Crinetics Pharmaceuticals
Price$35.61
Change+$1.36 (+3.97%)
Volume$1.42M
Capitalization3.35B
CNTA vs CRNX Comparison Chart in %
Loading...
CNTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CNTA vs. CRNX commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTA is a StrongBuy and CRNX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (CNTA: $15.73 vs. CRNX: $35.61)
Brand notoriety: CNTA and CRNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNTA: 90% vs. CRNX: 152%
Market capitalization -- CNTA: $2.11B vs. CRNX: $3.35B
CNTA [@Biotechnology] is valued at $2.11B. CRNX’s [@Biotechnology] market capitalization is $3.35B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTA’s FA Score shows that 0 FA rating(s) are green whileCRNX’s FA Score has 0 green FA rating(s).

  • CNTA’s FA Score: 0 green, 5 red.
  • CRNX’s FA Score: 0 green, 5 red.
According to our system of comparison, CRNX is a better buy in the long-term than CNTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTA’s TA Score shows that 5 TA indicator(s) are bullish while CRNX’s TA Score has 5 bullish TA indicator(s).

  • CNTA’s TA Score: 5 bullish, 5 bearish.
  • CRNX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both CNTA and CRNX are a good buy in the short-term.

Price Growth

CNTA (@Biotechnology) experienced а -6.31% price change this week, while CRNX (@Biotechnology) price change was +14.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Reported Earning Dates

CNTA is expected to report earnings on Nov 17, 2025.

CRNX is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($3.35B) has a higher market cap than CNTA($2.11B). CNTA YTD gains are higher at: -6.090 vs. CRNX (-30.354). CNTA has higher annual earnings (EBITDA): -214.83M vs. CRNX (-419.62M). CRNX has more cash in the bank: 1.2B vs. CNTA (251M). CRNX has less debt than CNTA: CRNX (49.9M) vs CNTA (118M). CNTA has higher revenues than CRNX: CNTA (15M) vs CRNX (1.39M).
CNTACRNXCNTA / CRNX
Capitalization2.11B3.35B63%
EBITDA-214.83M-419.62M51%
Gain YTD-6.090-30.35420%
P/E RatioN/AN/A-
Revenue15M1.39M1,078%
Total Cash251M1.2B21%
Total Debt118M49.9M236%
FUNDAMENTALS RATINGS
CRNX: Fundamental Ratings
CRNX
OUTLOOK RATING
1..100
23
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
PROFIT vs RISK RATING
1..100
64
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CNTACRNX
RSI
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
89%
Bearish Trend 3 days ago
86%
Momentum
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
74%
MACD
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 6 days ago
83%
Bullish Trend 5 days ago
75%
Declines
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 19 days ago
77%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
89%
Bearish Trend 3 days ago
84%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
CNTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GAHPX27.830.26
+0.94%
Goldman Sachs Emerging Markets Eq P
MINGX43.660.23
+0.53%
MFS International Intrinsic Value R3
GSYPX44.130.19
+0.43%
Goldman Sachs Small Cap Value P
MOSFX9.23N/A
N/A
MassMutual Overseas R4
SGFCX46.71-0.21
-0.45%
Sparrow Growth C

CNTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNTA has been loosely correlated with NRIX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if CNTA jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTA
1D Price
Change %
CNTA100%
-0.38%
NRIX - CNTA
45%
Loosely correlated
+8.66%
CRNX - CNTA
45%
Loosely correlated
+3.97%
RVMD - CNTA
43%
Loosely correlated
+3.98%
XENE - CNTA
43%
Loosely correlated
+1.48%
IDYA - CNTA
43%
Loosely correlated
+5.15%
More